 Constellation Pharmaceuticals Inc NASDAQ: CNST is trading higher Wednesday morning after an announcement that MorphoSys AG NASDAQ: MOR will acquire the company. What Happened: Constellation and MorphoSys entered into a definitive agreement in which MorphoSys will acquire Constellation for 34 per share, which represents a total equity value of 1.7 billion. 